Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kite Pharma Inc (NASDAQ:KITE)

59.58
BATS BZX Real-Time Price
As of 9:51am ET
 +1.54 / +2.65%
Today’s Change
38.41
Today|||52-Week Range
89.84
-3.31%
Year-to-Date
2 Clinical-Stage Biotech Stocks to Buy
8:05am / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close58.04
Today’s open57.95
Day’s range57.95 - 59.58
Volume1,421
Average volume (3 months)788,453
Market cap$2.9B
Dividend yield--
Data as of 9:51am ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-21.99%
Earnings growth (this year)-146.62%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales155.81
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp+0.58+2.28%
JUNOJuno Therapeutics In...+0.04+0.13%
NKTRNektar Therapeutics-0.02-0.12%
RDUSRadius Health Inc+0.12+0.22%
Data as of 9:51am ET, 08/30/2016

Financials

Next reporting dateNovember 11, 2016
EPS forecast (this quarter)-$1.61
Annual revenue (last year)$17.3M
Annual profit (last year)-$101.7M
Net profit margin-589.02%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Arie S. Belldegrun
Chief Operating Officer
Cynthia M. Butitta
Corporate headquarters
Santa Monica, California

Forecasts

Search for Jobs